HMGB1 and atherosclerosis: HMGB1 is also confirmed to participate in atherosclerosis development and is targeted by miR-328 such that miR-328 overexpression inhibits inflammation, oxidative stress, and apoptosis of ox-LDL-treated HUVECs (7).